IMR Press / FBL / Volume 28 / Issue 4 / DOI: 10.31083/j.fbl2804070
Open Access Original Research
Evaluation on the Effectiveness of High Cholesterol Diet Feeding in Inducing Early and Established Atherosclerotic Lesions in New Zealand White Rabbits
Show Less
1 Institute of Pathology, Laboratory and Forensic Medicine (I-PPerForM), Universiti Teknologi MARA, 47000 Sungai Buloh, Selangor, Malaysia
2 Department of Pathology, Faculty of Medicine, Universiti Teknologi MARA, 47000 Sungai Buloh, Selangor, Malaysia
3 Department of Biochemistry & Molecular Medicine, Faculty of Medicine, Universiti Teknologi MARA, 47000 Sungai Buloh, Selangor, Malaysia
*Correspondence: noor202@uitm.edu.my (Noor Alicezah Mohd Kasim)
Front. Biosci. (Landmark Ed) 2023, 28(4), 70; https://doi.org/10.31083/j.fbl2804070
Submitted: 2 February 2023 | Revised: 6 March 2023 | Accepted: 21 March 2023 | Published: 6 April 2023
Copyright: © 2023 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Background: Various methods were used to induce atherosclerosis in rabbits. One of the most common methods used is high-cholesterol diet (HCD) feeding. However, the exact amount and duration of HCD feeding to induce early and established atherosclerosis in New Zealand white rabbits (NZWR) continue to be debated among researchers. Therefore, this study aims to evaluate the effectiveness of 1% HCD feeding in inducing early and established atherosclerosis lesions in NZWR. Methods: A total of 50 g/kg/day of 1% HCD was fed to three to four months old male rabbits weighing 1.8 to 2.0 kg for four and eight weeks to induce early and established atherosclerosis respectively. The body weight and lipid profile were measured at baseline and post-HCD intervention. Following euthanasia, the aorta was excised and prepared for histology and immunohistochemical analysis to confirm the stages of atherosclerosis. Results: The mean body weight of the rabbits in early and established atherosclerosis groups increased significantly up to 17.5% (p = 0.026) and 19.75% (p = 0.019) respectively compared to baseline. The total cholesterol level dramatically elevated up to 13-fold (p = 0.005) and 38-fold (p = 0.013) compared to baseline, after four and eight weeks of 1% HCD feeding respectively. The low-density lipoprotein level significantly increased up to 42-fold (p = 0.006) and 128-fold (p = 0.011) compared to baseline, after four and eight weeks of 1% HCD feeding respectively. Rabbits fed with four and eight weeks 1% HCD significantly developed 5.79% (p = 0.008) and 21.52% (p = 0.008) aortic lesion areas compared to the control group. Histological evaluation in the aorta showed accumulation of foam cells in early atherosclerosis group and formation of fibrous plaque and lipid core in the established atherosclerosis group. Rabbits fed with eight weeks HCD showed higher tissue expressions of ICAM-1, VCAM-1, e-selectin, IL-6, IL-8, NF-κBp65, and MMP-12 compared to four weeks of HCD intervention. Conclusions: A total of 50 g/kg/day of 1% HCD for four and eight weeks is sufficient to induce early and established atherosclerosis in NZWR respectively. The consistent results through this method could facilitate researchers in inducing early and established atherosclerosis in NZWR.

Keywords
cholesterol
rabbits
lipid profile
immunohistochemistry
atherosclerosis
1. Introduction

It is estimated that 17.9 million people die each year from cardiovascular disease (CVD), accounting for 31% of all deaths worldwide [1]. Atherosclerosis is one of the major causes of CVD [2]. It is an arterial disease associated with dyslipidemia, abnormal arterial calcification, and oxidative stress. It has been shown that the chronic inflammatory state of the arterial wall contributes to the development of atherosclerosis [3]. The risk factors of atherosclerosis include hyperlipidemia, hypertension, smoking, insulin resistance, diabetes, obesity, inflammation, stress, and others [4]. There are several development stages of atherosclerosis. In early atherosclerosis, foam cells could be detected microscopically with the absence of plaque formation while established atherosclerosis could be differentiated from early atherosclerosis through the macroscopic presence of atherosclerotic plaque [5].

The use of animal models, especially rabbits, is essential to provide a better comprehension of the underlying pathological mechanism of atherosclerosis so that improved strategies and interventions can be formulated for the treatment of atherosclerosis. Rabbits were the first experimental animal model used specifically for atherosclerosis research. Besides, the stages of atherosclerotic lesions in rabbits also closely resemble those of humans [6]. Both rabbits and humans show a high expression of very-low-density lipoprotein (VLDL) receptors, which promote the foam cells to form, as compared to mice that do not [7]. Moreover, rabbits exhibit abundant cholesteryl ester transfer protein (CETP) in the plasma which regulates cholesterol metabolism, as opposed to mice and rats [8].

Due to these resemblances to humans, rabbits were the first animal model used to test many hypolipidemic drugs, including statins [9, 10] fibrates [11, 12] and probucol [13, 14, 15]. The anti-atherogenic effects of the infusion of high-density lipoproteins were also first established in cholesterol-fed rabbits [16, 17]. Besides, a systematic review concluded that HCD fed rabbits represented the best model to study the cholesterol-lowering activity of statins [18].

Earlier studies have shown that the animal model of choice for atherosclerosis induction was the Watanabe heritable hyperlipidemic (WHHL) rabbits that were of genetically atherogenesis-prone strain. They were widely used in the screening of drugs against atherosclerosis during the development stage. However, WHHL rabbits are costly and difficult to manage. Another model that can be used to induce atherosclerosis in rabbits is by using transgenic or genetically modified rabbits such as apolipoprotein E knockout (ApoE-/-) rabbits [19]. However, they are quite expensive and not readily available in some countries. As a result, the New Zealand White rabbits (NZWR) were fed with cholesterol and used as the replacement because they were more suitable and cost-effective for the induction of atherosclerosis [20].

Several reviews on the utilization of rabbits in atherosclerosis research have been published recently [6, 21, 22]. Each review contributed valuable components to this study. Fan et al. [6] provided an overview of recent progress on how rabbits can be used as a practical alternative to humans for the study of atherosclerosis. Lee et al. [21] focused on describing numerous species used in the atherosclerosis models, including rabbits, where they discussed the practicality of their use in experimentation. Finally, a review by Baumgartner et al. [22] described the investigations of therapeutic interventions in rabbits and the measurements of relevant parameters in vivo and ex vivo.

Despite decades of research, the exact amount and duration of high-cholesterol diet feeding to induce early and established atherosclerosis in NZWR continues to be debated among researchers. Therefore, this study would be beneficial for researchers who are new to the concept of working with rabbits. In short, we aimed to evaluate the effectiveness of a 1% high-cholesterol diet for four and eight weeks in the induction of early and established atherosclerosis in NZWR.

2. Materials and Methods
2.1 Materials

The standard normal diet (ND) was purchased from A Sapphire Enterprise (001303794-M) whereas the high-cholesterol diet (HCD) 1% was purchased from Specialty Feeds, Western Australia (SF00-221). Low-density lipoprotein cholesterol Gen.3 (LDLC3) for Cobas c 501 was obtained from Roche Diagnostic (Basel, Switzerland). The monoclonal antibodies for Interleukin 6, Interleukin 8 and Intercellular Adhesion Molecule 1 were purchased from MyBioSource (San Diego, CA, USA) while NF-κBp65 (F-6) (Code: sc-8008), E-Selectin (D-7) (Code: sc-137054) and MMP-12 (G-2) (Code: sc-390863) were obtained from Santa Cruz Biotechnology Inc. (Dallas, TX, USA). Hematoxylin (Code: S330130) was purchased from DAKO (Santa Clara, CA, USA). All other reagents used were of analytical grade unless otherwise stated.

2.2 Composition of High Cholesterol Diet

The HCD is composed of 18% protein, 4% total fat, 13% crude fiber, 13% A delta fiber whereas the digestible energy is 11 MJ/kg. The HCD is made up of barley, lupins, oaten hay, oat hulls, lucerne, soya meal, canola meal, DL-methionine (also known as racemethionine, is a mixture of two enantiomers D-methionine and L-methionine), magnesium oxide, dicalcium phosphate, salt, mixed vegetable oils, United States Pharmacopoeia (USP) cholesterol and a vitamin and mineral premix. The mineral contents of the HCD composed of 1.10% calcium, 0.70% phosphorus, 0.30% magnesium, 0.20% sodium, 1.10% potassium, 0.20% sulphur, 356 mg/kg iron, 23 mg/kg copper, 1.8 mg/kg iodine, 126 mg/kg manganese, 0.7 mg/kg cobalt, 95 mg/kg zinc, 1.0 mg/kg molybdenum, 0.3 mg/kg selenium, 0.008 mg/kg cadmium and 3.4 mg/kg boron. The HCD contains 48,640 IU/kg of vitamin A, 60 mg/kg of vitamin E, 3.3 mg/kg of vitamin K, 5.6 mg/kg of vitamin B1, 6.6 mg/kg of vitamin B2, 56 mg/kg of niacin, 5.7 mg/kg of vitamin B6, 19 mg/kg of pantothenic acid, 141 μg/kg of biotin, 0.6 mg/kg of folic acid, 7.3 μg/kg of vitamin B12 and 2270 mg/kg of choline. The calculated amino acids of the HCD are composed of 0.80% valine, 1.20% leucine, 0.70% isoleucine, 0.60% threonine, 0.20% methionine, 0.20% cystine, 0.76% lysine, 0.80% phenylamine, 0.50%, tyrosine, 0.20% tryptophan, and 0.44% histidine. The HCD was stored at 25 °C, which follows the recommended storage by the supplier.

2.3 Experimental Design and Intervention

A total of 15 male NZWR aged 3–4 months old with body weights of 1.8 to 2.0 kg were used. For the induction of early and established atherosclerosis, the NZWR were given HCD for 4 weeks and 8 weeks to promote atherogenesis for the development of early and established atherosclerotic lesions.

The experimental protocol is depicted below (Fig. 1). A total of 15 rabbits were randomized into the control group, group A (n = 5) and HCD group (n = 10). Rabbits in the control group were given a normal diet i.e., the chow pellet for two weeks while the HCD group was further divided into two groups which were group B (n = 5) and group C (n = 5). Group B was fed with 50 grams/kg/day of HCD for 4 weeks to induce early atherosclerosis while group C was fed with the same amount for 8 weeks to induce established atherosclerosis. The key readout parameters include the assessment of body weight, serum biochemical marker analysis, morphological examination, histopathological analysis and immunohistochemical analysis.

Fig. 1.

Experimental protocol to induce early and established atherosclerosis in rabbits.

2.4 Biochemical and Morphological Analysis

Rabbit’s blood was collected at baseline and after completing the 4 and 8 weeks of HCD feeding for Group B (Fig. 2) and Group C (Fig. 3) respectively. Rabbits were fasted for ten hours from 10 pm to 8 am the next morning. A total of 8 ml of blood was taken from either the marginal ear vein or the central ear artery of the rabbits.

Fig. 2.

Rabbit study timeline for group B (early atherosclerosis).

Fig. 3.

Rabbit study timeline for group C (established atherosclerosis).

Following that, the blood samples were centrifuged at 4000 rpm for 10 minutes to obtain the serum. Aliquoted serum was stored at –80 °C until analysis. The samples were then analyzed for lipid profile which include direct low-density lipoprotein cholesterol (LDL), total cholesterol (TC), triglycerides (TG), and high-density lipoprotein (HDL). All the tests were analyzed on automated analyzer, Roche Cobas c 501 (Indianapolis, IN, USA). Direct LDL was used because it is more precise than calculated LDL and it is not influenced by other lipid profile components [23]. All the tests were measured based on the standard calibration procedure and quality control check as per guidelines in the laboratory.

At the end of the experiment, the rabbits were euthanized with sodium pentobarbital (100 mg/kg) intravenously. The whole length of aorta was obtained after dissection to evaluate the atherosclerotic lesions. The aorta must be isolated to facilitate the macroscopic evaluation of the aortic lesions in terms of size and quality. The dissection started from the ascending aorta down to the bifurcation of the iliac arteries. The inner surface of the aorta was stained with Sudan IV according to the method in previous study [24].

First, the aortas were gently rinsed with normal saline before being cut open longitudinally to expose the lumen. The opened aortas were then pinned flat on a cardboard in a stainless-steel tray (8 × 16 cm) and fixed with 10% neutral buffered formalin overnight. After the process, the aortic vessels were taken out from the immersion and washed with 70% ethanol before being immersed in Herxheimer solution (5 g of Sudan IV dissolved in 500 mL 70% ethanol and 500 mL acetone) for 15 minutes at room temperature. Lastly, they were rinsed under running tap water for one hour. The stained aortic vessels were put on smooth contrast background imaging so that the entire areas of the aortic vessels could be captured at ultra-zoom with a digital camera C-740 Ultra Zoom, Olympus (Philadelphia, PA, USA). Quantitative analysis using image analysis software ImageJ, National Institute of Health (Bethesda, MD, USA) was done to obtain the percentage of Sudan IV-stained atherosclerotic regions before using it to calculate the percentage of the lesion area to the total aortic area.

2.5 Histopathological and Immunohistochemical Analysis

For histological evaluation, three different areas of aortic tissue were sampled, i.e., 10 mm away from the aortic arch, 10 mm away from upper thoracic, and 10 mm above the iliac bifurcation. Each section measured 15 mm in length (Fig. 4). All the aortic specimens of the rabbits were fixed in 10% formalin solution before grossing was performed and the tissues were placed in tissue cassettes. The tissues were then processed using an automated tissue processor MICROM STP120, Thermo Scientific™ (Waltham, MA, USA) for 21 hours (Table 1). The processed tissues were embedded in paraffin using Tissue-Tek® TEC™ (Torrance, CA, USA) to form paraffin-embedded tissue blocks and sectioned to 4–6 μm thickness, then ran through a rehydration process, and stained with Tissue-Tek® hematoxylin and eosin (H&E) Staining Kit, Sakura (Torrance, CA, USA). The sections were evaluated for the type of atherosclerosis formation (early/established/complicated) by a histopathologist, who is blinded of the experimental groups.

Fig. 4.

Schematic diagram of the aortic tissue of rabbits and selected lesion sites for section analyses.

Table 1.Program schedule for tissue processing using MICROM STP120.
No. Chemical/Reagent Quantity Duration (Hour)
1 10% Formalin 1.8 liters 2:00
2 50% Alcohol 1:00
3 70% Alcohol 1:00
4 80% Alcohol 1:00
5 95% Alcohol 1:00
6 Absolute Alcohol 2:00
7 Absolute Alcohol 2:00
8 Mixture of absolute alcohol and xylene (1:1) 1:00
9 Xylene 2:00
10 Xylene 2:00
11 Paraffin wax 3:00
12 Paraffin wax 3:00

Three different sites of aortic tissue were sampled with each section measuring 15 mm in length. The number in parentheses indicates the representative areas of each part of the artery selected for tissue section and the measurement of intimal lesion areas. (1) At the origin of the aortic arch; (2) at the origin of the abdominal aorta; (3) at the end of abdominal aorta before the bifurcation of iliac artery.

Immunohistochemical (IHC) staining for all antibodies; endothelial activation biomarkers (intracellular adhesion molecule-1 (ICAM-1), vascular cell adhesion mole-cule-1 (VCAM-1), and e-selectin), inflammatory biomarkers (interleukin-6 (IL-6), interleukin-8 (IL-8), and nuclear factor kappa B (NF-κB) and matrix metalloproteinases 12 (MMP-12) was performed using Dako Animal Research Kit (ARK), Peroxidase. Tissue sections were subjected to deparaffinization and rehydration before the IHC procedures were performed. Slides were subjected to pre-treatment with antigen retrieval pH 9.0 by heating in a microwave for 20 minutes and cooled down to room temperature for 20 minutes. Slides were kept in a moist chamber to avoid dehydration during IHC procedures.

The IHC was commenced by incubation of slides in peroxidase block for 10 minutes to reduce non-specific background staining. Slides were washed 3 times using wash buffer at 5 minutes interval and followed by application of primary antibodies at 1:150 dilutions. The antibodies were incubated overnight at 4 °C. Slides were washed thoroughly and the tissue was subjected to biotinylated primary antibody for 1 hour and followed by streptavidin-peroxidase application for another hour. Slides were then washed and subjected to application of DAB and substrate-chromogen for 5 minutes. The sections were then immersed in distilled water for 5 minutes, stained with hematoxylin and subsequently dehydrated through 50, 70, 80, 95, and 100% ethanol for 3 min each, and then cleared in xylene. Finally, the sections were mounted with dibutylphthalate polystyrene xylene (DPX) and glass coverslips, and allowed to dry. The specificity of the immunostaining was confirmed using negative control experiment in which primary antibodies were substituted with antibody diluent.

2.6 Statistical Analysis

The Statistical Analysis Package for Social Sciences (SPSS) for Windows, Version 27.0 (Chicago, IL, USA) was used for all analyses. All the data were tested for normality using the Shapiro-Wilk test. The results were expressed as mean ± standard error of mean (SEM). Paired t-test was used to compare the body weight and lipid profile before and after treatment. The comparison of the mean percentage of area covered by atherosclerotic plaque was measured between the groups using the Mann Whitney U test. Semiquantitative method was done to assess the expression of the biomarkers for immunohistochemical analysis. p-value < 0.05 was considered as statistically significant.

3. Results
3.1 The Effects of High Cholesterol Diet on the Body Weights of Rabbits

The mean body weight of group B and group C increased significantly up to 17.5% (p = 0.026) and 19.75% (p = 0.019) respectively compared to before treatment (B0) (Fig. 5).

Fig. 5.

Changes in body weight of rabbits after fed with normal diet for 2 weeks (Group A), high-cholesterol diet for 4 weeks (Group B) and 8 weeks (Group C). B0: before consumption of ND and HCD; B1: after consumption of ND and HCD. 1 vs. before treatment (B0), p = 0.026; 2 vs. before treatment (B0), p = 0.019.

3.2 The Effects of High Cholesterol Diet on the Lipid Profile of Rabbits

After 4 weeks feeding of 1% HCD, serum TC dramatically elevated up to 13-fold which is from 0.83 mmol/L to 10.68 mmol/L (p = 0.005). Accordingly, 8 weeks feeding of 1% HCD causes an increase of TC up to 38-fold, which is from 1.01 mmol/L to 38.63 mmol/L (p = 0.013). The LDL level significantly increased up to 42-fold, from 0.26 mmol/L to 10.83 mmol/L (p = 0.006) in group B whereas in group C, the LDL elevated up to 128-fold which is from 0.32 mmol/L to 40.93 mmol/L (p = 0.011). The TG level decreased from 0.67 mmol/L to 0.26 mmol/L (p = 0.025) in group B, while the HDL level significantly increased up to 3-fold in group B and C. The HDL in group B increased from 0.49 mmol/L to 1.24 mmol/L (p = 0.014) while in group C, the HDL increased from 0.45 mmol/L to 1.3 mmol/L (p = 0.008) (Table 2).

Table 2.Lipid profile of rabbits before and after high-cholesterol diet feeding.
Parameters (mmol/L) 4 weeks HCD 8 weeks HCD
Before treatment (B0)
TC 0.83 ± 0.14 1.01 ± 0.19
LDL 0.26 ± 0.05 0.32 ± 0.18
TG 0.67 ± 0.13 1.24 ± 0.18
HDL 0.49 ± 0.11 0.45 ± 0.04
After treatment (B1)
TC 10.68 ± 1.871 38.63 ± 8.942
LDL 10.83 ± 2.013 40.93 ± 9.244
TG 0.26 ± 0.025 1.5 ± 0.5
HDL 1.24 ± 0.226 1.3 ± 0.187

Values are expressed as the mean ± SEM (standard error of the mean) of five rabbits; TC, Total cholesterol; LDL, Low-density lipoprotein; TG, Triglyceride; HDL, High-density lipoprotein. 1 vs. before treatment (B0), p = 0.005; 2 vs. before treatment (B0), p = 0.013; 3 vs. before treatment (B0), p = 0.006; 4 vs. before treatment (B0), p = 0.011; 5 vs. before treatment (B0), p = 0.025; 6 vs. before treatment (B0), p = 0.014; 7 vs. before treatment (B0), p = 0.008.

3.3 The Effects of High Cholesterol Diet on the Morphology of the Aorta

The control group, group A showed extremely little or relatively no atherosclerotic lesion (0.037%) while group B showed higher percentage of atherosclerotic lesions which is 5.79% (p = 0.008). Almost half of the aortic area was significantly covered with atherosclerotic lesions in group C (21.52%) (p = 0.008) due to pro-longed exposure of the aortic walls to cholesterol (Table 3 and Fig. 6).

Table 3.Percentage atherosclerotic lesions formed in the aorta of rabbits fed with normal diet and high cholesterol diet.
Group Relative Area (%)
A 0.04 ± 0.02
B 5.79 ± 2.561
C 21.52 ± 11.922

Values are expressed as the mean ± SEM (standard error of the mean) of five rabbits.

1 vs. control group (group A), p = 0.008; 2 vs. control group (group A), p = 0.008.

Fig. 6.

Quantification of the atherosclerotic lesions of rabbits’ aorta using ImageJ (NIH, USA). (A) Rabbits fed with 2 weeks normal diet. (B) Rabbits fed with 4 weeks high-cholesterol diet. (C) Rabbits fed with 8 weeks high-cholesterol diet.

3.4 The Effects of High Cholesterol Diet on the Histology of the Aorta

The histological examination of aorta in group A, the control group showed intact tunica intima with thin wavy corrugated endothelium, a normal subendothelial layer, and wavy internal elastic fibers. The tunica media is comprised of elastic fibers and smooth muscle. The outermost layer is the tunica adventitia and is made up of loose connective tissue (Figs. 7,8). In group B, the tunica intima showed the presence of focal thickening, filled with vacuolated cells or foam cells, resulting in the widening of the subendothelial layer (Fig. 9). The tunica intima of the aorta in group C showed intimal thickening with subendothelial collection of foam cells as well as formation of a lipid core and fibrous cap (Fig. 10).

Fig. 7.

A photomicrograph of a section of the aorta in group A stained by hematoxylin and eosin (10×). Aorta in group A showing tunica intima (thin arrow). Elastic fibers and smooth muscle make up the tunica media (thick arrow). The outermost layer is the tunica adventitia which made of loose connective tissue (arrowhead).

Fig. 8.

A photomicrograph in a section of aorta in group A stained by hematoxylin and eosin (40×). Aorta in group A showing tunica intima (thin arrow) with thin wavy corrugated endothelium and minimal sub-endothelial layer. Elastic fibers and smooth muscle make up the tunica media (thick arrow).

Fig. 9.

A photomicrograph of a section of aorta in group B stained by hematoxylin and eosin (10×). Aorta in group B showing intimal thickening with expansion of the subendothelial layer with accumulation of vacuolated cells or foam cell (thick arrow).

Fig. 10.

A photomicrograph of a section of aorta in group C stained by hematoxylin and eosin (10×). Aorta in group C showing intimal thickening with subendothelial collection of foam cells, formation of lipid core (LC) with an overlying fibrous cap (FC).

3.5 The Effects of High Cholesterol Diet on the Immunohistochemical Staining of the Aorta

Immunoreactions of ICAM-1, VCAM-1, e-selectin, IL-6, IL-8, NF-κBp65 and MMP-12 were shown in Table 4. All the antibodies mentioned above were not expressed in the aortas of normal diet rabbits, i.e., group A. Positive brown staining of the macrophages and endothelium were seen in both groups B and C. However, higher expression of all the antibodies was observed in group C compared to group B.

Table 4.Immunohistochemical findings on eight biomarkers of atherosclerosis in the aortas of the rabbits (10×).
Control 4 weeks HCD 8 weeks HCD
E-selectin
VCAM-1
ICAM-1
IL-6
IL-8
NF-κB p65
MMP-12

According to the percentage endothelial staining of cells, semi-quantitative scores were applied. Score: 0 (negative); 1+ (1–10% positive cells); 2+ (11–25% positive cells) and 3+ (>25% positive cells).

4. Discussion

There are various methods available to induce atherosclerosis in rabbits which include oral feeding with HCD, inducing injury to the aorta of the rabbits and by combination of high fat diet, intravenous injection of bovine albumin and arterial injury. Balloon injury of the aortas or wire injury of the iliac arteries in rabbits can help in developing atherosclerotic lesions. This method may also be conducted in rabbits fed with cholesterol to accelerate the lesion formation. However, atherosclerotic lesions induced by injuries are primarily composed of “neo-intima” that are formed by proliferating smooth muscle cells as compared to fatty streaks induced by cholesterol diet feeding [6]. A study by Tian et al. [25] found a novel method to induce atherosclerosis in rabbits by using ferric chloride to stimulate injury in the right common carotid artery of rabbits. However, spontaneous intraplaque hemorrhage, plaque rupture, and thrombus were not observed by using this method. Another method is by combining several methods which are high-fat diet feeding, intravenous injection of bovine albumin and induction of arterial injury [26]. Though this method is time saving and cost effective, there are several restrictions that need to be followed to accomplish the same atherosclerotic model. Researchers need to be very precise in calculating the dosage of albumin and anesthesia to prevent the loss of rabbits. Moreover, only trained and expert researchers could proceed with this method as there are lots of technical details that need to be considered. For instance, excessive force during arterial injury could damage the arterial wall, rupture the blood vessels and cause rabbits to die [26].

One of the safe and established methods to induce atherosclerosis and hyperlipidemia in rabbits is by feeding HCD. However, the percentage of cholesterol and the duration of feeding varies between studies. For instance, Lorenz et al. [27] fed a high-cholesterol diet containing 0.5% cholesterol to rabbits for 4 weeks. Another study by Ibrahim et al. [28] fed the rabbits with a 120-gram 1% cholesterol diet daily for 90 days while Ram et al. [29] fed the NZWR with a 200-gram high-fat diet per day (500 mg cholesterol mixed with 5 mL coconut oil/kg orally) for 15 days to induce atherosclerosis. Qiao et al. [26] induced atherosclerosis in Japanese big-ear rabbits by feeding 50-gram high-fat diet (2% cholesterol, 10% lard, 10% egg yolk powder, 0.2% propylthiouracil, and 67.8% regular diet) daily for seven weeks. Majeed et al. [30] kept the rabbits on a cholesterol-rich diet (2% cholesterol) for 12 weeks whereas Wang et al. [31] induced atherosclerosis in the Male Japanese White rabbits by giving a 0.3% cholesterol diet (100 g/day) for 16 weeks. Even though the duration of feeding and the percentage of cholesterol differed between the abovementioned studies, all the methods led to an increased lipid profile and the development of some kind of atherosclerotic lesions in the rabbits.

Rabbits have more tissue due to their bigger sizes compared to rodents. Thus, a single rabbit is adequate to perform multiple analyses. As a result, the use of rabbits should be considered in translational research involving the development of new lipid-lowering and anti-atherosclerotic therapeutic drugs. Furthermore, rabbits were the first experimental animal model used specifically for atherosclerosis research. They are particularly suitable for this purpose due to the distinctive features of their lipid metabolism [32].

Similar to humans, the major plasma lipoproteins in rabbits are LDL while mice have HDL as their major plasma lipoproteins. In addition, mice have no CETP while rabbits and humans have abundant CETP. Humans and rabbits exhibit a similar type of apoB-48, which is made up of chylomicrons. The apoB-100 in humans and rabbits are also similar, where they can be bound to apo (a), while apo (a) in mice do not. HDL is heterogeneous in rabbits and humans, while homogeneous in mice. Like humans, rabbits exhibit VLDL receptors in their macrophages as opposed to mice. Furthermore, the cholesterol pool in rabbits and humans are mainly from hepatic synthesis, whereas, in mice, the pool is mainly from dietary origin. The ability to excrete bile acid derived from cholesterol is low in humans and rabbits, whereas, high in mice. Furthermore, rabbits and humans are very sensitive to cholesterol diets compared to mice [32].

The present study further characterized the effects of consumption of 1% HCD for 4 weeks and 8 weeks on the body weight, lipid profile, morphology and histology of aorta in the rabbits. In this study, it was observed that the body weight of rabbits fed with 8 weeks HCD was higher than the body weight of rabbits fed with 4 weeks HCD. This is consistent with earlier studies [33, 34] which showed that dietary treatment of rabbits with high-cholesterol diets causes significant weight gain.

The significant increase of TC and LDL post HCD feeding might be correlated with an increased risk of atherosclerosis [35]. This was confirmed by positive and significant correlations between total plasma cholesterol and atherosclerosis degree in our experiment in which higher increase in the percentage of TC and LDL showed higher percentage of atherosclerotic lesions.

In fact, elevated levels of plasma TC and LDL concentrations after HCD consumption have been recorded in earlier studies and shown to contribute to the development of atherosclerotic plaques [36]. On the other hand, it is suggested that HCD accelerate atherogenesis through increasing blood viscosity and disturbing the mechanical fragility of atherosclerotic plaques hence making them vulnerable to rupture and thrombosis [37].

Hypercholesterolemia in rabbits is due to the accumulation of exogenous cholesterol. Rabbits easily developed atherosclerosis by feeding HCD since they are unable to increase sterol excretion [32]. Therefore, high amount of cholesteryl ester-rich lipoproteins was exported into the circulation by the liver causing hypercholesterolemia to occur.

The inconsistent results of the TG levels may be due to variations in responses to HCD and plasma lipid levels in each rabbit. Such variations in lipids will certainly affect the extent of atherosclerosis. Therefore, it is vital to adjust the cholesterol intake and carefully screen the animals before performing the experiment so that rabbits with similar responsiveness to cholesterol will be selected for the experiment [38].

An increase in the HDL levels may be due to the composition of HCD that act as cholesteryl ester transfer protein (CETP) inhibitors. According to Javandoost et al. [39], HDL is elevated by the inhibition of CETP. CETP inhibitors prevent the transfer of cholesteryl esters from HDL towards apo B containing lipoproteins in exchange for triglycerides and therefore increases plasma HDL level [40]. Besides, CETP only exists in humans and a few laboratory animals, such as rabbits, guinea pigs, and hamsters, whereas mice and rats do not [41]. Another possibility of high HDL level is due to deficiency of CETP in the rabbits. A study by Zhang et al. [42] demonstrated that genetic ablation of the CETP gene in rabbits led to increase in plasma HDL.

Besides, the HCD composition could also contribute to the rise of HDL level. The HCD (SF00-221) contains several vitamins such as vitamin A, vitamin K, vitamin E, vitamin B1, vitamin B2, niacin (Nicotinic acid), vitamin B6, calcium pantothenate and vitamin B12. Some of these vitamins, for example, niacin, are evident to raise HDL level by decreasing the hepatic CETP expression and plasma levels of CETP [43]. Furthermore, niacin has been shown to selectively increases the plasma levels of apolipo-protein-A1 in patients with low HDL [44].

The histological results of this study agree that the severity of the atherosclerotic lesions in the aorta is associated with hypercholesterolemia, which is one of the most important risk factors of endothelial dysfunction in human arteries [45, 46]. In this study, the histology analysis confirmed that HCD can cause atherosclerotic lesions formation in a time-dependent manner. These histopathological results are parallel to the biochemical and morphological findings in this study. This is in agreement with other literatures that showed HCD feeding is responsible for the thickening of tunica intima and the formation of foam cells [28, 46].

Medium to high expressions of adhesion molecules, such as ICAM-1, VCAM-1 and e-selectin were observed in the aortas of rabbits fed with HCD. This represents the initiation of the lesion stage, where the endothelial cells have been stimulated by the ox-LDL to express the adhesion molecules, which could lead to the recruitment of monocytes and transmigrate into the intima by diapedesis as well as differentiate into pro-atherogenic macrophages [47]. An increased expression of pro-inflammatory biomarkers, such as IL-6, IL-8 and NF-κB p65 was also observed in the endothelium and macrophages of the aorta in rabbits fed with HCD for 4 and 8 weeks. A fatty streak was formed at this stage due to the accumulation of lipid-laden foam cells in the intimal layer of the artery. Over time without treatment or change in diets and lifestyles, the fatty streak could evolve into a fibrous plaque, which is observed in the aorta of rabbits fed with HCD for 8 weeks. MMP-12 expression was higher in the aorta of rabbits fed with HCD for 8 weeks. Our findings were parallel with the results of a previous study, which found that MMP-12 increases the transformation of fatty streaks into fibrous plaques and hastens the onset of atherosclerosis in transgenic rabbits [48].

As scientifically proven in our study, there are several inflammatory biomarkers that participate in all stages of atherosclerosis. The inflammatory processes incite the induction and development of atheroma, and at the same time contribute significantly to hastening the acute thrombotic complications of atheroma [49]. Interestingly, a previous study found that treatment with canakinumab reduced inflammatory biomarkers without reducing LDL levels, resulting in a significantly lower incidence of recurrent cardiovascular events [50].

Therefore, the comprehensive method in this study can be useful for the researchers, as most of the current studies not only focused on LDL lowering agents but also on the suppression of inflammatory processes [51], including inflammasomes. Recently, emerging evidence showed that inflammasomes play a significant role in the inflammatory processes related to atherosclerosis and other cardiovascular diseases. Accumulating evidence supports the notion that the activation of inflammasomes such as nucleotide-binding domain leucine-rich repeat pyrin domain containing 1 (NLRP1), nucleotide-binding domain leucine-rich repeat pyrin domain containing 3 (NLRP3), nucleotide-binding domain leucine-rich repeat family caspase activation and recruitment domains (CARD) containing 4 (NLRC4), and absent in melanoma 2 (AIM2) triggered by cardiovascular disease risk factors plays a pivotal role in the progression of atherosclerosis [52].

In recent years, the role of gasdermins in atherosclerosis has received much attention. Gasdermins are a family of pore-forming effector proteins that cause membrane permeabilization and pyroptosis, a lytic form of cell death [53]. One of these proteins, gasdermin D (GSDMD), has been identified as the final executor of the inflammasome activity. A recent study has shown that GSDMD is involved in multiple pro-inflammatory pathways that promote atherosclerosis progression [54]. Besides, interesting results from a previous study found that a deficiency in GSDMD reduced the formation of inflammatory plaques and delayed the progression of atherosclerotic plaque in ApoE-/- mice [55].

However, further investigations and more research are needed to explore these areas so that promising therapeutic approaches can be developed for the treatment and prevention of atherosclerosis. Future studies aimed at identifying and describing new triggers and mechanisms regulating atherosclerosis development are encouraged to use the method described in this study.

5. Conclusions

This study confirms that 50 g/kg of 1% HCD feeding for 4- and 8-weeks duration is effective in inducing early and established atherosclerosis in NZWR. This is evident by the significant increase in the body weight, LDL and TC levels in the intervention groups which are in parallel with the histological and immunohistochemical results. Compared to other methods, HCD feeding is a non-time consuming, easy to maintain and affordable method that can be used in atherosclerosis studies. However, researchers need to be extra careful in planning the experiment that relates to HDL. Nevertheless, this study could provide new insights into the understanding of atherosclerosis and expand the power of the rabbit model for translational research in atherosclerosis besides facilitating future research experiments in discovering potential preventions and treatments to reduce atherosclerosis.

Availability of Data and Materials

All data generated or analyzed during this study are included in this published article.

Author Contributions

NAMK, EO and HN designed the research study. INAR performed the research. NAMK, EO, SAM and HN provided help and advice on conception, acquisition of data and supervision. INAR, NAMK and EO analyzed the data. INAR wrote the manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript.

Ethics Approval and Consent to Participate

All experiments were conducted in an appropriate animal experimentation facility. The animal experiments in this study were approved by and conducted in conformity with the rules and regulations of the Universiti Teknologi MARA Committee on Animal Research & Ethics (UiTM CARE). The ethical approval number was UiTM CARE: 326/2020.

Acknowledgment

The authors would like to acknowledge the Institute of Medical Molecular Biotechnology (IMMB) and Laboratory Animal Care Unit (LACU) of Faculty of Medicine, Universiti Teknologi MARA for providing the facilities to complete this study.

Funding

This research was funded by the Ministry of Higher Education Malaysia under Fundamental Research Grant Scheme, grant number (FRGS) 600-IRMI/FRGS 5/3 (366/2019).

Conflict of Interest

The authors declare no conflict of interest.

References
[1]
World Health Organization. Cardiovascular diseases (CVDs). 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (Accessed: 3 January 2023).
[2]
Frostegård J. Immunity, atherosclerosis and cardiovascular disease. BMC Medicine. 2013; 11: 117.
[3]
Xiao X, Yang C, Qu SL, Shao YD, Zhou CY, Chao R, et al. S100 proteins in atherosclerosis. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2020; 502: 293–304.
[4]
Hajar R. Risk Factors for Coronary Artery Disease: Historical Perspectives. Heart Views. 2017; 18: 109–114.
[5]
Rahman TA, Hassim NF, Zulkafli N, Muid S, Kornain NK, Nawawi H. Atheroprotective effects of pure tocotrienol supplementation in the treatment of rabbits with experimentally induced early and established atherosclerosis. Food & Nutrition Research. 2016; 60: 31525.
[6]
Fan J, Chen Y, Yan H, Niimi M, Wang Y, Liang J. Principles and Applications of Rabbit Models for Atherosclerosis Research. Journal of Atherosclerosis and Thrombosis. 2018; 25: 213–220.
[7]
Takahashi S, Ito T, Zenimaru Y, Suzuki J, Miyamori I, Takahashi M, et al. Species differences of macrophage very low-density-lipoprotein (VLDL) receptor protein expression. Biochemical and Biophysical Research Communications. 2011; 407: 656–662.
[8]
Wang Z, Niimi M, Ding Q, Liu Z, Wang L, Zhang J, et al. Comparative studies of three cholesteryl ester transfer proteins and their interactions with known inhibitors. PLoS ONE. 2017; 12: e0180772.
[9]
Shiomi M, Koike T, Ito T. Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins. Atherosclerosis. 2013; 231: 39–47.
[10]
Luo F, Guo Y, Ruan GY, Long JK, Zheng XL, Xia Q, et al. Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet. Scientific Reports. 2017; 7: 2169.
[11]
Corti R, Osende J, Hutter R, Viles-Gonzalez JF, Zafar U, Valdivieso C, et al. Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI. Atherosclerosis. 2007; 190: 106–113.
[12]
Fournier N, Tuloup-Minguez V, Pourci ML, Thérond P, Jullian JC, Wien F, et al. Fibrate treatment induced quantitative and qualitative HDL changes associated with an increase of SR-BI cholesterol efflux capacities in rabbits. Biochimie. 2013; 95: 1278–1287.
[13]
Niimi M, Keyamura Y, Nozako M, Koyama T, Kohashi M, Yasufuku R, et al. Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits. Lipids in Health and Disease. 2013; 12: 166.
[14]
Keyamura Y, Nagano C, Kohashi M, Niimi M, Nozako M, Koyama T, et al. Add-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatin. PLoS ONE. 2014; 9: e96929.
[15]
Wang Y, Bai L, Lin Y, Chen Y, Guan H, Zhu N, et al. Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits. Lipids in Health and Disease. 2015; 14: 82.
[16]
Badimon JJ, Badimon L, Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. The Journal of Clinical Investigation. 1990; 85: 1234–1241.
[17]
Badimon JJ, Badimon L, Galvez A, Dische R, Fuster V. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Laboratory Investigation. 1989; 60: 455–461.
[18]
Pecoraro V, Moja L, Dall’Olmo L, Cappellini G, Garattini S. Most appropriate animal models to study the efficacy of statins: a systematic review. European Journal of Clinical Investigation. 2014; 44: 848–871.
[19]
Emini Veseli B, Perrotta P, De Meyer GRA, Roth L, Van der Donckt C, Martinet W, et al. Animal models of atherosclerosis. European Journal of Pharmacology. 2017; 816: 3–13.
[20]
Fan J, Watanabe T. Cholesterol-fed and transgenic rabbit models for the study of atherosclerosis. Journal of Atherosclerosis and Thrombosis. 2000; 7: 26–32.
[21]
Lee YT, Laxton V, Lin HY, Chan YWF, Fitzgerald-Smith S, To TLO, et al. Animal models of atherosclerosis. Biomedical Reports. 2017; 6: 259–266.
[22]
Baumgartner C, Brandl J, Münch G, Ungerer M. Rabbit models to study atherosclerosis and its complications - Transgenic vascular protein expression in vivo. Progress in Biophysics and Molecular Biology. 2016; 121: 131–141.
[23]
Cohen H. Why Should We Measure Low-Density Lipoprotein Cholesterol Directly? Comparison of Low-Density Lipoprotein Cholesterol Assessment by Friedewald Estimation, and Direct Measurement. Journal of the Endocrine Society. 2021; 5: A305.
[24]
Hamm TE, Jr, Kaplan JR, Clarkson TB, Bullock BC. Effects of gender and social behavior on the development of coronary artery atherosclerosis in cynomolgus macaques. Atherosclerosis. 1983; 48: 221–233.
[25]
Tian J, Hu S, Sun Y, Ban X, Yu H, Dong N, et al. A novel model of atherosclerosis in rabbits using injury to arterial walls induced by ferric chloride as evaluated by optical coherence tomography as well as intravascular ultrasound and histology. Journal of Biomedicine & Biotechnology. 2012; 2012: 121867.
[26]
Qiao Y, Zhu K, Bo Z, Yu Z, Han Y, Zhao Q, et al. A method of rapid rabbit atherosclerosis model establishment. Biomedical Research. 2017; 28: 7614–7618.
[27]
Lorenz M, Fechner M, Kalkowski J, Fröhlich K, Trautmann A, Böhm V, et al. Effects of lycopene on the initial state of atherosclerosis in New Zealand White (NZW) rabbits. PLoS ONE. 2012; 7: e30808.
[28]
Ibrahim M, Ahmed IA, Mikail MA, Ishola AA, Draman S, Isa MLM, et al. Baccaurea angulata fruit juice reduces atherosclerotic lesions in diet-induced Hypercholesterolemic rabbits. Lipids in Health and Disease. 2017; 16: 134.
[29]
Ram H, Jatwa R, Purohit A. Antiatherosclerotic and Cardioprotective Potential of Acacia senegal Seeds in Diet-Induced Atherosclerosis in Rabbits. Biochemistry Research International. 2014; 2014: 436848.
[30]
Majeed ML, Ghafil FA, Fatima G, Hadi NR, Mahdi HF. Anti-Atherosclerotic and Anti-Inflammatory Effects of Curcumin on Hypercholesterolemic Male Rabbits. Indian Journal of Clinical Biochemistry: IJCB. 2021; 36: 74–80.
[31]
Wang W, Chen Y, Bai L, Zhao S, Wang R, Liu B, et al. Transcriptomic analysis of the liver of cholesterol-fed rabbits reveals altered hepatic lipid metabolism and inflammatory response. Scientific Reports. 2018; 8: 6437.
[32]
Fan J, Kitajima S, Watanabe T, Xu J, Zhang J, Liu E, et al. Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacology & Therapeutics. 2015; 146: 104–119.
[33]
Park D, Kyung J, Kim D, Hwang SY, Choi EK, Kim YB. Anti-hypercholesterolemic and anti-atherosclerotic effects of polarized-light therapy in rabbits fed a high-cholesterol diet. Laboratory Animal Research. 2012; 28: 39–46.
[34]
Yelaware Puttaswamy N, Urooj A. In Vivo Antihypercholesterolemic Potential of Swietenia mahagoni Leaf Extract. Cholesterol. 2016; 2016: 2048341.
[35]
Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 1986; 2: 933–936.
[36]
Sloop GD. A critical analysis of the role of cholesterol in atherogenesis. Atherosclerosis. 1999; 142: 265–268.
[37]
Abdelhalim MAK, Siiddiqi NJ, Alhomida AS, Al-Ayed MS. Effects of feeding periods of high cholesterol and saturated fat diet on blood biochemistry and hydroxyproline fractions in rabbits. Bioinformatics and Biology Insights. 2008; 2: 95–100.
[38]
Kolodgie FD, Katocs AS, Jr, Largis EE, Wrenn SM, Cornhill JF, Herderick EE, et al. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Arteriosclerosis, Thrombosis, and Vascular Biology. 1996; 16: 1454–1464.
[39]
Javandoost A, Afshari A, Nikbakht-Jam I, Khademi M, Eslami S, Nosrati M, et al. Effect of crocin, a carotenoid from saffron, on plasma cholesteryl ester transfer protein and lipid profile in subjects with metabolic syndrome: A double blind randomized clinical trial. ARYA Atherosclerosis. 2017; 13: 245–252.
[40]
Antman EM. Cardiovascular Therapeutics E-Book: A Companion to Braunwald’s Heart Disease. Elsevier Health Sciences: Philadelphia. 2012.
[41]
Ha YC, Barter PJ. Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comparative Biochemistry and Physiology. B, Comparative Biochemistry. 1982; 71: 265–269.
[42]
Zhang J, Niimi M, Yang D, Liang J, Xu J, Kimura T, et al. Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits. Arteriosclerosis, Thrombosis, and Vascular Biology. 2017; 37: 1068–1075.
[43]
van der Hoorn JWA, de Haan W, Berbée JFP, Havekes LM, Jukema JW, Rensen PCN, et al. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008; 28: 2016–2022.
[44]
Ganji SH, Kamanna VS, Kashyap ML. Niacin and cholesterol: role in cardiovascular disease (review). The Journal of Nutritional Biochemistry. 2003; 14: 298–305.
[45]
Amran AA, Zakaria Z, Othman F, Das S, Raj S, Nordin NAMM. Aqueous extract of Piper sarmentosum decreases atherosclerotic lesions in high cholesterolemic experimental rabbits. Lipids in Health and Disease. 2010; 9: 44.
[46]
Hasan ST, Zingg JM, Kwan P, Noble T, Smith D, Meydani M. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice. Atherosclerosis. 2014; 232: 40–51.
[47]
Steinl DC, Kaufmann BA. Ultrasound imaging for risk assessment in atherosclerosis. International Journal of Molecular Sciences. 2015; 16: 9749–9769.
[48]
Yamada S, Wang KY, Tanimoto A, Fan J, Shimajiri S, Kitajima S, et al. Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits. The American Journal of Pathology. 2008; 172: 1419–1429.
[49]
Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105: 1135–1143.
[50]
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. The New England Journal of Medicine. 2017; 377: 1119–1131.
[51]
Ridker PM. From CANTOS to CIRT to COLCOT to Clinic: Will All Atherosclerosis Patients Soon Be Treated With Combination Lipid-Lowering and Inflammation-Inhibiting Agents? Circulation. 2020; 141: 787–789.
[52]
Liao Y, Liu K, Zhu L. Emerging Roles of Inflammasomes in Cardiovascular Diseases. Frontiers in Immunology. 2022; 13: 834289.
[53]
Broz P, Pelegrín P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nature Reviews. Immunology. 2020; 20: 143–157.
[54]
Opoku E, Traughber CA, Zhang D, Iacano AJ, Khan M, Han J, et al. Gasdermin D Mediates Inflammation-Induced Defects in Reverse Cholesterol Transport and Promotes Atherosclerosis. Frontiers in Cell and Developmental Biology. 2021; 9: 715211.
[55]
Puylaert P, Van Praet M, Vaes F, Neutel CHG, Roth L, Guns PJ, et al. Gasdermin D Deficiency Limits the Transition of Atherosclerotic Plaques to an Inflammatory Phenotype in ApoE Knock-Out Mice. Biomedicines. 2022; 10: 1171.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share
Back to top